A French study included 54 patients with early-onset PD treated with STN-DBS, out of which seven had biallelic parkin mutations (homozygous or compound heterozygous) and seven had one identified mutation.38 Twelve months postoperatively, patients with biallelic mutations had significantly lower LEDD than mutation-negative patients. Here, PRKN is linked to Parkinson disease.